According to the Zhitong Finance App, Peijia Medical-B (09996.HK) announced that the GeminiOne® transcatheter edge repair (“TEER”) system (“GeminiOne®”) independently developed by the company has recently been approved by the China Drug Administration (“State Drug Administration”) of the People's Republic of China (“State Drug Administration”).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.